Whittier Trust Co. Buys 27,439 Shares of Intuitive Surgical, Inc. $ISRG

Whittier Trust Co. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 41.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 92,965 shares of the medical equipment provider’s stock after buying an additional 27,439 shares during the period. Whittier Trust Co.’s holdings in Intuitive Surgical were worth $50,517,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after buying an additional 453,335 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after buying an additional 71,794 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after buying an additional 11,988 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after buying an additional 457,080 shares during the last quarter. Finally, Nuveen LLC bought a new position in shares of Intuitive Surgical in the 1st quarter worth $1,715,899,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 2.8%

NASDAQ:ISRG opened at $458.47 on Tuesday. The company has a fifty day moving average of $454.70 and a 200 day moving average of $495.81. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a market capitalization of $164.35 billion, a P/E ratio of 63.94, a P/E/G ratio of 4.69 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same period in the prior year, the business posted $1.78 EPS. The firm’s revenue was up 21.4% compared to the same quarter last year. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares in the company, valued at $325,669.91. This represents a 31.19% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 in the last three months. 0.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ISRG. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a report on Wednesday, October 8th. Truist Financial cut their price objective on shares of Intuitive Surgical from $600.00 to $525.00 and set a “buy” rating for the company in a research note on Wednesday, October 15th. Robert W. Baird cut their price objective on shares of Intuitive Surgical from $600.00 to $536.00 and set an “outperform” rating for the company in a research note on Wednesday, October 15th. Mizuho cut their price objective on shares of Intuitive Surgical from $570.00 to $520.00 and set a “neutral” rating for the company in a research note on Tuesday, October 14th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Fourteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $580.29.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.